Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve

Julio F Marchini1,2, Ayumi Aurea Miyakawa3, Flavio Tarasoutchi4

  • 1Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of São Paulo Medical School, São Paulo, SP, Brazil. jfmarchini@usp.br.

Abstract

Insights

Percutaneous aortic valve replacement (TAVR) did not acutely alter circulating microparticle (MP) levels in patients with severe aortic stenosis. This suggests TAVR does not immediately impact the prothrombotic and proinflammatory state associated with this condition.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biomaterials Science

Background:

  • Severe aortic stenosis is linked to elevated prothrombotic and proinflammatory microparticles (MPs).
  • Abnormal shear stress in aortic stenosis stimulates MP production, contributing to atherothrombotic events.

Purpose of the Study:

  • To investigate the effect of transcatheter aortic valve replacement (TAVR) on circulating microparticle levels in severe aortic stenosis patients.
  • To determine if TAVR reduces abnormal shear stress and consequently decreases MP levels.

Main Methods:

  • Quantification of circulating plasma microparticle (MP) levels using flow cytometry (FC) and nanoparticle tracking analysis (NTA).
  • MP levels were measured at baseline and 5 days post-TAVR in patients with severe aortic stenosis.

Main Results:

  • No significant acute change in overall circulating MP levels was observed 5 days after TAVR (p = 0.91 for both FC and NTA).
  • Stratification by cell source revealed no significant differences in pre/post-TAVR endothelial, platelet, or leukocyte MP levels.

Conclusions:

  • Circulating microparticle levels do not acutely change following TAVR for aortic stenosis.
  • The prothrombotic and proinflammatory state associated with aortic stenosis may not be immediately resolved by TAVR.